OnDemand WTP Pricing Research

Angioplasty costs down 8-18% post stent price cut, says study | Livemint

Mumbai: The cost of angioplasty procedures has declined by 8-18% following the government’s decision to slash prices of coronary stents by up to 80% in February last year, a study conducted by IQVIA, formerly QuintilesIMS, on behalf of Advanced Medical Technology Association (AdvaMed), showed.

The 8-18% reduction in overall angioplasty procedure cost is for patients undergoing single vessel procedure, which forms around 70% of the total number of patients undergoing angioplasty.

An angioplasty surgery is performed in cardiac patients to open blocked arteries. A stent, a tiny tube-shaped device, is placed in the patient’s narrowed or blocked coronary artery to maintain normal blood supply.

The National Pharmaceutical Pricing Authority (NPPA) had cut prices of coronary stents sharply last year in a bid to make angioplasty affordable and improve access. Price of widely used drug-eluting stents, which used to be earlier priced as high as Rs200,000 was brought down to Rs30,000 by the regulator.

AdvaMed, a lobby group representing international medical device companies, along with IQVIA, conducted the study to understand the impact of stent price control on the overall angioplasty procedure cost and the total number of angioplasties performed across hospital segments.

Read complete article here:

Angioplasty costs down 8-18% post stent price cut, says study – Livemint.